<doc>
  <docmeta id="113hr3303ih">
    <bill congress="113" type="hr" number="3303" version="ih"/>
    <revision size="7453" annotations="0" status="complete" id="3" commit-time="2013-11-04T23:17:34Z" committer="mbohmer" doc="113hr3303ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HC2A0CB359D834018BB4C12AF754A26E8" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 3303 IH: Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-10-22</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>1st Session</session>
    <legis-num>H. R. 3303</legis-num>
    <current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
    <action>
      <action-date date="20131022">October 22, 2013</action-date>
      <action-desc>
        <sponsor name-id="B001243">Mrs. Blackburn</sponsor> (for herself, <cosponsor name-id="G000410">Mr. Gene Green of Texas</cosponsor>, <cosponsor name-id="W000791">Mr. Walden</cosponsor>, <cosponsor name-id="D000197">Ms. DeGette</cosponsor>, <cosponsor name-id="B001251">Mr. Butterfield</cosponsor>, and <cosponsor name-id="G000550">Mr. Gingrey of Georgia</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To amend the Federal Food, Drug, and Cosmetic Act to provide for regulating medical software, and for other purposes.</official-title>
  </form>
  <legis-body id="HFD1C1E4759E84058895E0CC74D32A7FC" style="OLC">
    <section id="HE650ACD280F6466F908F42DFB877D87A" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013</short-title>
        </quote> or the <quote>
          <short-title>SOFTWARE Act of 2013</short-title>
        </quote>.</text>
    </section>
    <section id="H1F6C3BB69EC4477688C29F52825DC626">
      <enum>2.</enum>
      <header>Medical software</header>
      <subsection id="H47DCE4F0676B476EA992C1BB38C5EF96">
        <enum>(a)</enum>
        <header>Definition of medical software</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201">Section 201 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/321">
              <cato:entity-ref entity-type="uscode" value="usc/21/321">21 U.S.C. 321</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
        <quoted-block id="H52FE35D6E443423EA4D59946997C18B5" style="OLC">
          <subsection id="H7326C19FEAA447C68802DE9CAD8CC31E">
            <enum>(ss)</enum>
            <text>The term <term>medical software</term> means software that is intended for human or animal use and—</text>
            <paragraph id="HACA2C376C6844A14BF602F6E5E4641F1">
              <enum>(1)</enum>
              <subparagraph commented="no" display-inline="yes-display-inline" id="H9EF7EDBF658B4079852AEBF76C81229F">
                <enum>(A)</enum>
                <text>is intended to be marketed to directly change the structure or any function of the body of man or other animals; or</text>
              </subparagraph>
              <subparagraph id="HBC53AE372B7148F0A73E8B84C9AAA9D3" indent="up1">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">is intended to be marketed for use by consumers and makes recommendations for clinical action that—</text>
                <clause id="HA89B583EF7514A4D93FFCCB5DD5E9EFB">
                  <enum>(i)</enum>
                  <text display-inline="yes-display-inline">includes the use of a drug, device, or procedure to cure or treat a disease or other condition without requiring the involvement of a health care provider; and</text>
                </clause>
                <clause id="H991F95DA836D410CB294E236E884D09B">
                  <enum>(ii)</enum>
                  <text>if followed, would change the structure or any function of the body of man or other animals;</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="H494466C7E4DF4274993A4CFAA400687A">
              <enum>(2)</enum>
              <text>is not software whose primary purpose is integral to the functioning of a drug or device; and</text>
            </paragraph>
            <paragraph id="H6310EFB0340E4DD6B6DA87F010C47DD6">
              <enum>(3)</enum>
              <text>is not a component of a device.</text>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="H093BA840286448F3B8081F94AFB552F0">
        <enum>(b)</enum>
        <header>Regulation</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:A">Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/351">
              <cato:entity-ref entity-type="uscode" value="usc/21/351/etseq">21 U.S.C. 351 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="H49D7FB46344C4048B45F3ABB70CC13C4" style="OLC">
          <section id="HCEBB1733287543E993D774748FE3890D">
            <enum>524B.</enum>
            <header>Medical software</header>
            <subsection id="HA7CA86A123744CBB92D3A597DCD2AEBD">
              <enum>(a)</enum>
              <header>In general</header>
              <text>The provisions of this Act shall apply with respect to medical software to the same extent and in the same manner as such provisions apply with respect to devices.</text>
            </subsection>
            <subsection id="HCDE1AC3C94C3430BA40C8B278E616D0F">
              <enum>(b)</enum>
              <header>Delegation</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Secretary</cato:entity-ref> shall delegate primary jurisdiction for regulating medical software to the center at the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> charged with regulating devices.</text>
            </subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
    </section>
    <section id="HCD0B3ACEB7004610BA79B0DF5D2A801C">
      <enum>3.</enum>
      <header>Clinical software and health software</header>
      <subsection id="HC04552F940384861BDA6480A58589778">
        <enum>(a)</enum>
        <header>Definitions</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201">Section 201 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/321">
              <cato:entity-ref entity-type="uscode" value="usc/21/321">21 U.S.C. 321</cato:entity-ref>
            </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:2/ss:a" proposed="true">section 2(a)</cato:entity-ref>, is further amended by adding at the end the following:</text>
        <quoted-block id="H65E50991137E47CC95D0B0B7ABC89719" style="OLC">
          <subsection id="H6EF4DF95515F40F98EBAAEB684E7B296">
            <enum>(tt)</enum>
            <paragraph commented="no" display-inline="yes-display-inline" id="HACBCF4EE9735420585B8E9546CAD8E15">
              <enum>(1)</enum>
              <text>The term <term>clinical software</term> means clinical decision support software or other software (including any associated hardware and process dependencies) intended for human or animal use that—</text>
              <subparagraph id="H11E712252B2444DE9B9A83C42CE1195A" indent="up1">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">captures, analyzes, changes, or presents patient or population clinical data or information and may recommend courses of clinical action, but does not directly change the structure or any function of the body of man or other animals; and</text>
              </subparagraph>
              <subparagraph id="H7A841109199E4D0482D1CDC6538EE4FA" indent="up1">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">is intended to be marketed for use only by a health care provider in a health care setting.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="H958DB500F88C45CB9B87F89B8A52C3BB" indent="up1">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">The term <term>health software</term> means software (including any associated hardware and process dependencies) that is not medical software or clinical software and—</text>
              <subparagraph id="H745B7C2519814B89A608A2ACA12938FF">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">that captures, analyzes, changes, or presents patient or population clinical data or information;</text>
              </subparagraph>
              <subparagraph id="H37D407F02AE549FE81B87B97E0E4D7AC">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">that supports administrative or operational aspects of health care and is not used in the direct delivery of patient care; or</text>
              </subparagraph>
              <subparagraph id="HC79BC1D06EE44AD594529D1233B44001">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">whose primary purpose is to act as a platform for a secondary software, to run or act as a mechanism for connectivity, or to store data.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="HED3C780B154D4A5BBB1311BE87DBDC8F">
        <enum>(b)</enum>
        <header>Prohibition</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V/sch:A">Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/351">
              <cato:entity-ref entity-type="uscode" value="usc/21/351/etseq">21 U.S.C. 351 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:2/ss:b" proposed="true">section 2(b)</cato:entity-ref>, is further amended by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="H255ADF25ED3446B59ECF3F5A075CF2AF" style="OLC">
          <section id="HFF7A1EF1351346C0A0810B972977E863">
            <enum>524C.</enum>
            <header>Clinical software and health software</header>
            <text display-inline="no-display-inline">Clinical software and health software shall not be subject to regulation under this Act.</text>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="HEA2FE09BCD974815A9258A9D61227D0E">
        <enum>(c)</enum>
        <header>Sense of Congress</header>
        <text>It is the sense of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> that—</text>
        <paragraph id="H1A7C2FCAC3B34094B87561243F072CDD">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">clinical software and health software (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:tt" proposed="true">section 201(tt) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013/s:3/ss:a" proposed="true">subsection (a)</cato:entity-ref>)—</text>
          <subparagraph id="H74A8733332DF47718B8FB6DE550189DF">
            <enum>(A)</enum>
            <text>advance the goals of enhanced patient safety and continued innovation;</text>
          </subparagraph>
          <subparagraph id="H2FEFF604694D4007978A2C2F30B966F1">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">hold much promise to lower costs and improve the health of patients; and</text>
          </subparagraph>
          <subparagraph id="H45CB7606F98E43528C8285BD4B3E9ACF">
            <enum>(C)</enum>
            <text>can improve the quality and efficacy of health care provider services; and</text>
          </subparagraph>
        </paragraph>
        <paragraph id="HC6173FB522D248F1940F1EE6F85F934F">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1100">President</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> should work together to develop and enact legislation that establishes a risk-based regulatory framework for such clinical software and health software that reduces regulatory burdens, promotes patient safety, and fosters innovation.</text>
        </paragraph>
      </subsection>
    </section>
    <section id="H7538C9872189467DB904AD87EEB20300">
      <enum>4.</enum>
      <header>Exclusion from definition of device</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:h">Section 201(h) of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/321">
            <cato:entity-ref entity-type="uscode" value="usc/21/321">21 U.S.C. 321</cato:entity-ref>
          </external-xref>)</cato:entity> is amended—</text>
      <paragraph id="HA68A3F9060E04B7FBF597D8D8BFD527E">
        <enum>(1)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:2">paragraph (2)</cato:entity-ref>, by striking <quote>
            <short-title>or other animals, or</short-title>
          </quote> and inserting <quote>
            <short-title>or other animals,</short-title>
          </quote>;</text>
      </paragraph>
      <paragraph id="H476926064B6846A78B3F6386F1C272B7">
        <enum>(2)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:3">paragraph (3)</cato:entity-ref>, by striking <quote>
            <short-title>and</short-title>
          </quote>; and</text>
      </paragraph>
      <paragraph id="HF802F74E682C4A58AFC9799C18F8263B">
        <enum>(3)</enum>
        <text>by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:201/ss:h/p:3">paragraph (3)</cato:entity-ref> the following new paragraphs:</text>
        <quoted-block display-inline="no-display-inline" id="H70983CEDE77D434F9D96F19421E1A017" style="OLC">
          <paragraph id="HFFCC5FFBE3914B059331B2C72E4D21AF">
            <enum>(4)</enum>
            <text display-inline="yes-display-inline">is not medical software, or</text>
          </paragraph>
          <paragraph id="H75E228E03C784978BD656412048564EC">
            <enum>(5)</enum>
            <text display-inline="yes-display-inline">is not clinical software or health software, and</text>
          </paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </paragraph>
    </section>
  </legis-body>
</bill>
</doc>